1.Crosstalk between FLS and chondrocytes is regulated by HIF-2alpha-mediated cytokines in arthritis.
Yun Hyun HUH ; Gyuseok LEE ; Won Hyun SONG ; Jeong Tae KOH ; Je Hwang RYU
Experimental & Molecular Medicine 2015;47(12):e197-
Rheumatoid arthritis (RA) and osteoarthritis (OA), two common types of arthritis, affect the joints mainly by targeting the synovium and cartilage. Increasing evidence indicates that a significant network connects synovitis and cartilage destruction during the progression of arthritis. We recently demonstrated that hypoxia-inducible factor (HIF)-2alpha causes RA and OA by regulating the expression of catabolic factors in fibroblast-like synoviocytes (FLS) or chondrocytes. To address the reciprocal influences of HIF-2alpha on FLS and chondrocytes, we applied an in vitro co-culture system using a transwell apparatus. When co-cultured with HIF-2alpha-overexpressing chondrocytes, FLS exhibited increased expression of matrix metalloproteinases and inflammatory mediators, similar to the effects induced by tumor-necrosis factor (TNF)-alpha treatment of FLS. Moreover, chondrocytes co-cultured with HIF-2alpha-overexpressing FLS exhibited upregulation of Mmp3 and Mmp13, which is similar to the effects induced by interleukin (IL)-6 treatment of chondrocytes. We confirmed these differential HIF-2alpha-induced effects via distinct secretory mediators using Il6-knockout cells and a TNF-alpha-blocking antibody. The FLS-co-culture-induced gene expression changes in chondrocytes were significantly abrogated by IL-6 deficiency, whereas TNF-alpha neutralization blocked the alterations in gene expression associated with co-culture of FLS with chondrocytes. Our results further suggested that the observed changes might reflect the HIF-2alpha-induced upregulation of specific receptors for TNF-alpha (in FLS) and IL-6 (in chondrocytes). This study broadens our understanding of the possible regulatory mechanisms underlying the crosstalk between the synovium and cartilage in the presence of HIF-2alpha, and may suggest potential new anti-arthritis therapies.
Animals
;
Arthritis/genetics/*immunology/pathology
;
Arthritis, Rheumatoid/genetics/immunology/pathology
;
Basic Helix-Loop-Helix Transcription Factors/genetics/*immunology
;
Cells, Cultured
;
Chondrocytes/immunology/metabolism/*pathology
;
Coculture Techniques
;
Fibroblasts/immunology/metabolism/*pathology
;
Gene Expression Regulation
;
Interleukin-6/genetics/*immunology
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Osteoarthritis/genetics/immunology/pathology
;
Synovial Membrane/immunology/metabolism/*pathology
;
Tumor Necrosis Factor-alpha/genetics/*immunology
;
Up-Regulation
2.MRP8 promotes Th17 differentiation via upregulation of IL-6 production by fibroblast-like synoviocytes in rheumatoid arthritis.
Dong Gun LEE ; Jung Won WOO ; Seung Ki KWOK ; Mi La CHO ; Sung Hwan PARK
Experimental & Molecular Medicine 2013;45(4):e20-
Myeloid-related protein (MRP)8/MRP14 is an endogenous Toll-like receptor 4 (TLR4) ligand and is abundant in synovial fluid (SF) of rheumatoid arthritis (RA) patients. Belonging to damage-associated molecular patterns, it amplifies proinflammatory mediators and facilitates a wide range of inflammatory and autoimmune diseases. Interleukin (IL)-17-producing T-helper (Th)17 cells have a crucial role in RA pathogenesis, and IL-6 is the key factor promoting Th17 differentiation. We investigated whether the level of MRP8/MRP14 is positively associated with IL-6 and IL-17 levels in RA SF and found that MRP8/MRP14 level had a significant correlation with IL-6 and IL-17 levels in RA SF. We also observed that MRP8-induced IL-17 production by peripheral blood mononuclear cells but MRP14 did not. Upon stimulation with MRP8, IL-6 production was enhanced by RA fibroblast-like synoviocytes (FLS) and was further elevated by coculturing RA FLS with activated CD4+ T cells. Moreover, we demonstrated that MRP8-activated IL-6 production by RA FLS promoted differentiation of Th17 cells using the coculture system consisting of CD4+ T cells and RA FLS. In addition, IL-6 blockade attenuated Th17 polarization of CD4+ T cells in the cocultures. Inhibitor studies revealed that MRP8 increased IL-6 production in RA FLS via TLR4/phosphoinositide 3-kinase/nuclear factor-kappaB and mitogen-activated protein kinase signaling pathways. Our results show that MRP8 has a crucial role in stimulating IL-6 expression by RA FLS, and subsequently promotes Th17 differentiation in RA, suggesting that neutralizing MRP8 level in RA synovium may be an effective therapeutic strategy in RA treatment.
ATP-Binding Cassette Transporters/*metabolism
;
Adult
;
Aged
;
Arthritis, Rheumatoid/*pathology
;
CD4-Positive T-Lymphocytes/metabolism
;
Calgranulin B/metabolism
;
Cell Differentiation/*immunology
;
Fibroblasts/*metabolism/pathology
;
Humans
;
Inflammation Mediators/metabolism
;
Interleukin-17/metabolism
;
Interleukin-6/*biosynthesis
;
Middle Aged
;
Signal Transduction/immunology
;
Synovial Fluid/cytology
;
Synovial Membrane/metabolism/pathology
;
Th17 Cells/*pathology
;
Toll-Like Receptor 4/metabolism
;
*Up-Regulation
3.Regulation of B cell activating factor (BAFF) receptor expression by NF-kappaB signaling in rheumatoid arthritis B cells.
Yun Ju WOO ; Bo Young YOON ; Joo Yeon JHUN ; Hye Jwa OH ; Sewon MIN ; Mi La CHO ; Sung Hwan PARK ; Ho Youn KIM ; Jun Ki MIN
Experimental & Molecular Medicine 2011;43(6):350-357
B cells play an important role in the pathogenesis of rheumatoid arthritis (RA). High levels of B cell activating factor (BAFF) are detected in autoimmune diseases. BAFF and BAFF receptor (BAFF-R) are expressed in B and T cells of RA synovium. The study was undertaken to identify the NF-kappaB signal pathway involved in the induction of BAFF-R in human B cells. Immunohistochemical staining of NF-kappaB p65, NF-kappaB p50, BAFF, and BAFF-R was performed on sections of synovium from severe and mild RA and osteoarthritis (OA) patients. Peripheral blood mononuclear cells (PBMCs) were isolated from control and RA patients and B cells were isolated from controls. BAFF-R was analyzed by flow cytometry, realtime PCR and confocal staining after treatment with NF-kappaB inhibitors. NF-kappaB p65, NF-kappaB p50, BAFF, and BAFF-R were highly expressed in severe RA synovium relative to mild RA synovium or OA synovium. BAFF-R expression was reduced by NF-kappaB inhibitors in PBMCs and B cells from normal controls. We also showed reduction in expression of BAFF-R via inhibition of the NF-kappaB pathway in PBMCs of RA patients. BAFF/BAFF-R signaling is an important mechanism of pathogenesis in RA and that BAFF-R reduction by NF-kappaB blocking therapy is another choice for controlling B cells in autoimmune diseases such as RA.
Arthritis, Rheumatoid/genetics/*metabolism/pathology/physiopathology
;
B-Cell Activating Factor/genetics/metabolism
;
B-Cell Activation Factor Receptor/genetics/*metabolism
;
B-Lymphocytes/*drug effects/immunology/metabolism/pathology
;
Cell Separation
;
Cells, Cultured
;
Disease Progression
;
Enzyme Inhibitors/pharmacology
;
Flow Cytometry
;
Gene Expression Regulation/immunology
;
Humans
;
Immunohistochemistry
;
NF-kappa B/*metabolism
;
Signal Transduction/immunology
;
Synovial Membrane/*pathology
;
T-Lymphocytes/drug effects/immunology/metabolism/pathology
;
Transcriptional Activation/drug effects
4.Combination of AD5-10 and epirubicin in treating rheumatoid arthritis.
Jian-suo ZHOU ; Juan SHI ; Jie-qing ZHU ; Hai-qin YUAN ; Yan-xin LIU ; Xin YOU ; De-xian ZHENG
Acta Academiae Medicinae Sinicae 2011;33(4):367-370
OBJECTIVETo investigate the mechanism of anti-death receptor 5-10 (AD5-10) combined with epirubicin in treating rheumatoid arthritis (RA).
METHODSWe detected the cell viability of the fibroblast-like synoviocytes (FLS) from RA patients with MTT. The expression level of apoptosis signaling pathways protein, p53, and p21 were evaluated with Western blot.
RESULTSWe found that epirubicin, at different doses, could enhance the effect of AD5-10 on FLS, promoting the apoptosis of FLS. The expression levels of caspase-3, -8, -9, c-FLIP, Bcl-2, p53, and p21 in the FLS changed after epirubicin treatment.
CONCLUSIONEpirubicin may coordinate with AD5-10 in inducing FLS apoptosis through affecting the levels of p53, p21, c-FLIP, and Bcl-2.
Antibodies, Monoclonal ; pharmacology ; Apoptosis ; drug effects ; Apoptosis Regulatory Proteins ; metabolism ; Arthritis, Rheumatoid ; drug therapy ; metabolism ; pathology ; Cells, Cultured ; Epirubicin ; pharmacology ; Humans ; Receptors, TNF-Related Apoptosis-Inducing Ligand ; immunology ; Synovial Membrane ; cytology ; drug effects ; metabolism
5.Effects of Astragalus heteropolysaccharides on erythrocyte immune adherence function of mice with adjuvant-induced arthritis.
Li-Hu YANG ; Jian-Dong QIU ; Hong-Quan LI
Acta Pharmaceutica Sinica 2009;44(12):1364-1370
Astragalus heteropolysaccharides (AHPS) is obtained from the dried roots of Astragalus membranaceus (Fisch.) Bunge var. mongholious (Bunge) Hsiao. In the present study, we observed its effects on erythrocyte immune adherence function in mice with adjuvant-induced arthritis (AA). The mice were treated intragastrically with AHPS of 1 000, 500, and 250 mg x kg(-1) x d(-1) separately and treated with tripterygium glycosides (TG) of 60 mg x kg(-1) x d(-1) as positive control. The number of complement receptor type 1 (CR1) on erythrocyte, the concentration of circulating immune complex (CIC) in serum and the amount of immune complex (IC) deposition in synovium of knee joint were determined by flow cytometry, polyethylene glycol (PEG-6000) precipitation and ponceau S (P-S) staining and fluorescent immunohistochemistry respectively. The pathological change of knee joint was evaluated by histological section. The results showed that both AHPS and TG improved significantly the primary and secondary local or systemic symptoms of the mice with AA and reduced the synovium hyperplasia, inflammatory cell infiltrate, pannus and cartilage demolish of knee joint, and AHPS of 1 000, 500, and 250 mg x kg(-1) x d(-1) could significantly increase the number of CR1 on erythrocyte, improve the elimination of CIC in the peripheral blood and reduce the deposition of IC in joint synovium in a dose-dependent manner (P < 0.01 or P < 0.05). The results indicate that one of the therapeutic effective mechanisms of AHPS on mice with AA could be to increase gene expression of CR1 of mice with AA.
Animals
;
Antigen-Antibody Complex
;
blood
;
metabolism
;
Arthritis, Experimental
;
metabolism
;
pathology
;
Astragalus Plant
;
chemistry
;
Dose-Response Relationship, Drug
;
Erythrocytes
;
immunology
;
Knee Joint
;
pathology
;
Male
;
Mice
;
Plant Roots
;
chemistry
;
Plants, Medicinal
;
chemistry
;
Polysaccharides
;
administration & dosage
;
isolation & purification
;
pharmacology
;
Random Allocation
;
Receptors, Complement
;
blood
;
Synovial Membrane
;
immunology
6.Eupatilin Ameliorates Collagen Induced Arthritis.
Juryun KIM ; Youngkyun KIM ; Hyoju YI ; Hyerin JUNG ; Yeri Alice RIM ; Narae PARK ; Seung Min JUNG ; Sung Hwan PARK ; Ji Hyeon JU
Journal of Korean Medical Science 2015;30(3):233-239
Eupatilin is the main active component of DA-9601, an extract from Artemisia. Recently, eupatilin was reported to have anti-inflammatory properties. We investigated the anti-arthritic effect of eupatilin in a murine arthritis model and human rheumatoid synoviocytes. DA-9601 was injected into collagen-induced arthritis (CIA) mice. Arthritis score was regularly evaluated. Mouse monocytes were differentiated into osteoclasts when eupatilin was added simultaneously. Osteoclasts were stained with tartrate-resistant acid phosphatase and then manually counted. Rheumatoid synoviocytes were stimulated with TNF-alpha and then treated with eupatilin, and the levels of IL-6 and IL-1beta mRNA expression in synoviocytes were measured by RT-PCR. Intraperitoneal injection of DA-9601 reduced arthritis scores in CIA mice. TNF-alpha treatment of synoviocytes increased the expression of IL-6 and IL-1beta mRNAs, which was inhibited by eupatilin. Eupatilin decreased the number of osteoclasts in a concentration dependent manner. These findings, showing that eupatilin and DA-9601 inhibited the expression of inflammatory cytokines and the differentiation of osteoclasts, suggest that eupatilin and DA-9601 is a candidate anti-inflammatory agent.
Animals
;
Anti-Inflammatory Agents/pharmacology/*therapeutic use
;
Arthritis, Experimental/chemically induced/*drug therapy
;
Arthritis, Rheumatoid/drug therapy/pathology
;
Cell Differentiation/*drug effects
;
Cells, Cultured
;
Collagen Type II
;
Cytokines/biosynthesis
;
Disease Models, Animal
;
Drugs, Chinese Herbal/therapeutic use
;
Female
;
Flavonoids/pharmacology/*therapeutic use
;
Humans
;
Inflammation/drug therapy/immunology
;
Interleukin-1beta/genetics/metabolism
;
Interleukin-6/genetics/metabolism
;
Lymph Nodes/cytology
;
Mice
;
Mice, Inbred DBA
;
Monocytes/cytology
;
Osteoclasts/*cytology
;
Plant Extracts/pharmacology
;
RNA, Messenger/biosynthesis
;
Synovial Membrane/cytology
;
T-Lymphocytes, Regulatory/cytology/immunology
;
Tumor Necrosis Factor-alpha/pharmacology